Cytomegalovirus (HHV-5) Infections:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Cytomegalovirus (HHV-5) Infections 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Cytomegalovirus (HHV-5) Infections 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Hoffmann-La Roche Inc. 35
Clinical Trial Overview of Hoffmann-La Roche Inc. 35
ViroPharma Incorporated 36
Clinical Trial Overview of ViroPharma Incorporated 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Vical Incorporated 39
Clinical Trial Overview of Vical Incorporated 39
Isis Pharmaceuticals, Inc. 40
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 40
Chimerix, Inc. 41
Clinical Trial Overview of Chimerix, Inc. 41
Gilead Sciences, Inc. 42
Clinical Trial Overview of Gilead Sciences, Inc. 42
Theraclone Sciences, Inc. 43
Clinical Trial Overview of Theraclone Sciences, Inc. 43
Genentech, Inc. 44
Clinical Trial Overview of Genentech, Inc. 44
Amgen Inc. 45
Clinical Trial Overview of Amgen Inc. 45
Cell Medica Limited 46
Clinical Trial Overview of Cell Medica Limited 46
AiCuris GmbH & Co. KG 47
Clinical Trial Overview of AiCuris GmbH & Co. KG 47
Roche Global Development 48
Clinical Trial Overview of Roche Global Development 48
AlphaVax, Inc. 49
Clinical Trial Overview of AlphaVax, Inc. 49
Sandoz Inc. 50
Clinical Trial Overview of Sandoz Inc. 50
Astellas Pharma Inc. 51
Clinical Trial Overview of Astellas Pharma Inc. 51
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Merck & Co., Inc. 53
Clinical Trial Overview of Merck & Co., Inc. 53
Clinical Trial Overview of Top Institutes / Government 54
The National Institute of Allergy and Infectious Diseases 54
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 54
National Heart, Lung, and Blood Institute 57
Clinical Trial Overview of National Heart, Lung, and Blood Institute 57
National Eye Institute 58
Clinical Trial Overview of National Eye Institute 58
Baylor College of Medicine 59
Clinical Trial Overview of Baylor College of Medicine 59
National Center for Research Resources 60
Clinical Trial Overview of National Center for Research Resources 60
Fred Hutchinson Cancer Research Center 61
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 61
Hadassah Medical Organization 62
Clinical Trial Overview of Hadassah Medical Organization 62
University of California, San Francisco 63
Clinical Trial Overview of University of California, San Francisco 63
University of Alabama at Birmingham 64
Clinical Trial Overview of University of Alabama at Birmingham 64
National Taiwan University Hospital 65
Clinical Trial Overview of National Taiwan University Hospital 65
Kobe University 66
Clinical Trial Overview of Kobe University 66
University Hospital, Limoges 67
Clinical Trial Overview of University Hospital, Limoges 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
City of Hope National Medical Center 69
Clinical Trial Overview of City of Hope National Medical Center 69
Hospital do Rim e Hipertensao 70
Clinical Trial Overview of Hospital do Rim e Hipertensao 70
Washington University School of Medicine 71
Clinical Trial Overview of Washington University School of Medicine 71
Assistance Publique – Hopitaux de Paris 72
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 72
Duke University 73
Clinical Trial Overview of Duke University 73
Charles University 74
Clinical Trial Overview of Charles University 74
University of Pennsylvania 75
Clinical Trial Overview of University of Pennsylvania 75
Five Key Clinical Profiles 76
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 111


【レポート販売概要】

■ タイトル:Cytomegalovirus (HHV-5) Infections:グローバル臨床試験レビューH2, 2013
■ 英文:Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013
■ 発行日:2013年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161420
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。